Trademarkia Logo

Australia

AU$
LTP
Protected: Registered/protected

Last updated on 7 Apr 2022

Owner Info

Ligand Pharmaceuticals Incorporated

5980 Horton Street, Suite 405

Emeryville CA 94608, UNITED STATES OF AMERICA

Serial Number

2022262 filed on 4 Jun 2019

Correspondent

Lisa M. Martens Sheppard Mullin Richter & Hampton LLP

12275 El Camino Real, Suite 200,

San Diego CA 92130-2006,

UNITED STATES OF AMERICA

LTP

Classification Information


Class [042]
Pharmaceutical research and development of a process to deliver organ specific pharmaceutical preparations.

Mark Details


Serial Number

2022262

Registered On

4 Jun 2019

Renewal On

4 Jun 2029

Mark Type

WORD

Priority Claim (Convention Details)


Date

7 Dec 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Apr 2022Amendment to Amend Owner Requested
3rd Dec 2020Amendment to Amend Owner Requested
14th Jan 2020International Registration in Australia Protected correspondence sent
13th Jan 2020IP Right Registration Published
13th Jan 2020Status change to Registered/Protected
5th Nov 2019Application Accepted correspondence sent
4th Nov 2019IP Right Acceptance Published
4th Nov 2019IP Right has been Examined
4th Nov 2019Status change to Accepted
12th Jul 2019Examination expedited